These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12888929)

  • 21. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].
    Debourdeau P; Chahmi DK; Zammit C; Farge-Bancel D
    Pathol Biol (Paris); 2008 Jun; 56(4):211-9. PubMed ID: 18395994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
    Burris HA
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous thromboembolism: a clinical review.
    Osinbowale O; Ali L; Chi YW
    Postgrad Med; 2010 Mar; 122(2):54-65. PubMed ID: 20203456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood coagulation and cancer: thrombosis and survival, clinical relevance and impact. An introduction.
    Vestjens JH; Sassen S; Prins MH
    Pathophysiol Haemost Thromb; 2008; 36(3-4):113-21. PubMed ID: 19176984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warfarin versus low-molecular-weight heparin therapy in cancer patients.
    Zacharski LR; Prandoni P; Monreal M
    Oncologist; 2005 Jan; 10(1):72-9. PubMed ID: 15632254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
    Lee AY
    Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of venous thromboembolism.
    Nazario R; DeLorenzo LJ; Maguire GP; Dobkin J; Reichel J
    Heart Dis; 2000; 2(6):438-45. PubMed ID: 11728295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism in pediatrics.
    Anton N; Massicotte MP
    Semin Vasc Med; 2001; 1(1):111-22. PubMed ID: 15199521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.
    Palareti G; Legnani C; Lee A; Manotti C; Hirsh J; D'Angelo A; Pengo V; Moia M; Coccheri S
    Thromb Haemost; 2000 Nov; 84(5):805-10. PubMed ID: 11127860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated venous thrombosis in the surgical setting.
    Behranwala KA; Williamson RC
    Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer and thrombosis: managing the risks and approaches to thromboprophylaxis.
    Hiller E
    Onkologie; 2006 Oct; 29(10):474-8. PubMed ID: 17028457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outpatient management of anticoagulation therapy.
    du Breuil AL; Umland EM
    Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer-associated thrombosis: focus on extended therapy with dalteparin.
    Bick RL
    J Support Oncol; 2006 Mar; 4(3):115-20. PubMed ID: 16553136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism and cancer: prevention and therapy.
    Lee AY
    Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controversies in pulmonary embolism and deep venous thrombosis.
    Davidson BL
    Am Fam Physician; 1999 Nov; 60(7):1969-80. PubMed ID: 10569501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
    Levine M
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [How to provide practical treatment for ambulatory patients with deep venous thrombosis].
    Achkar A; Samama MM
    J Mal Vasc; 1999 Feb; 24(1):58-65. PubMed ID: 10192039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.